Phase II Non-randomized Study of a Atezolizumab (MPDL3280A) in Combination With Carboplatin Plus Pemetrexed in Patients Who Are Chemotherapy-naïve and Have Stage IV Non-squamous Non-small Cell Lung Cancer Twith Asymptomatic Brain Metastasis
Phase: PHASE2
Conditions: Non-small Cell Lung Cancer Stage IV
Sponsor: Spanish Lung Cancer Group

    
 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
CONFIDENTIAL 
 
 
 
 
 Official Title: 
 
 
 
NCT Number: 
 
 
 
Document Dates: Summary of Protocol Amendment Version 3.1:  
10 December 2020 
 
 
 
 
 
 
 
 
 
 
 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
2 
 
 
 
 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
3 
 
 
Contacts 
 
Trial Chair (Principal 
Investigator) 
Dr. Marta Simó  
Avenida Meridiana 358, 6ªplanta 
08027 Barcelona 
Tel. 93 430 20 06 
Fax. 93 419 17 68 
Email: 
pharmacovigilance.slcg@gecp.org 
 
Email: tbaz@gecp.org
Avenida Meridiana 358, 6ªplanta 
08027 Barcelona 
Tel. 93 430 20 06 
Fax. 93 419 17 68 
 
 
Anna Hernández 
Avenida Meridiana 358, 6ªplanta 
08027 Barcelona 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
4 
 
 
 
 
 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
5 
 
 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
6 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
7 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
8 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
9 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
10 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
11 
 
 
 
 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
12 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
13 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
14 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
15 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
16 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
17 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
18 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
19 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
20 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
21 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
22 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
23 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
24 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
25 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
26 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
27 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
28 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
29 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
30 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
31 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
32 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
33 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
34 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
35 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
36 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
37 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
38 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
39 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
40 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
41 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
42 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
43 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
44 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
45 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
46 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
47 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
48 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
49 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
50 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
51 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
52 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
53 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
54 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
55 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
56 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
57 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
58 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
59 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
60 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
61 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
62 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
63 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
64 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
65 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
66 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
67 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
68 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
69 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
70 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
71 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
72 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
73 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
74 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
75 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
76 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
77 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
78 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
79 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
80 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
81 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
82 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
83 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
84 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
85 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
CONFIDENTIAL 

 
 
 
 
 
 
Appendix 1-Schedule of Activities (cont.) 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
87 
 
 

 
 
 
 
 
 
Appendix 1-Schedule of Activities (cont.) 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
88 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
CONFIDENTIAL 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
90 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
91 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
92 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
93 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
94 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
95 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
96 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
CONFIDENTIAL 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
98 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
99 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
100 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
101 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
102 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
103 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
104 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
105 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
106 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
107 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
108 
 
 

 
ATEZO-BRAIN_GECP 17/05_v.3.1_10_December_2020 
109